AbbVie | ABBV - PE Price to Earnings

Stock Price
228.51
Daily Change
-0.97 -0.42%
Monthly
3.51%
Yearly
11.94%
Q1 Forecast
217.84

AbbVie reported $24.03 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Abbott USD 30.71 14.41 Dec/2025
ALKERMES USD 14.9 1.11 Sep/2025
Amgen USD 25.31 15.82 Dec/2025
AstraZeneca USD 27.29 5.8 Dec/2025
Biogen USD 14.02 4.63 Dec/2025
BioMarin Pharmaceutical USD 19.24 0.21 Dec/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Eisai JPY 26.63 0.46 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Gilead Sciences USD 15.63 0.08 Dec/2025
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
J&J USD 23.62 0.86 Dec/2025
Medtronic USD 22.76 1.32 Dec/2025
Merck USD 13.92 5.08 Dec/2025
Neurocrine Biosciences USD 835.47 802.2 Dec/2025
Novartis USD 15.74 0.15 Sep/2025
Pacira USD 29.24 6.15 Sep/2025
Perrigo USD 34.31 15.46 Sep/2025
Pfizer USD 14.48 5.18 Dec/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
UCB EUR 35.22 3.9 Jun/2025
United Therapeutics USD 15.7 4.24 Sep/2025
Vertex Pharmaceuticals USD 26.15 2.22 Dec/2025
Zoetis USD 20.42 2.84 Dec/2025